Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001193125-06-225226
Filing Date
2006-11-06
Accepted
2006-11-06 16:50:53
Documents
11
Period of Report
2006-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1150288
2 AGREEMENT DATED 1/18/2006 dex1027.htm EX-10.27 91198
3 AMENDMENT TO THE AGREEMENT DATED 3/6/2006 dex1028.htm EX-10.28 44578
4 AMENDMENT TO AGREEMENT BY AND BETWEEN THE COMPANY AND SCIREX CORPORATION dex1030.htm EX-10.30 84288
5 SUBSIDIARY OF THE COMPANY dex211.htm EX-21.1 1582
6 CONSENT OF ODENBERG, ULLAKKO, MURANISHI & CO., LLP dex231.htm EX-23.1 1973
7 CONSENT OF ERNST & YOUNG LLP dex232.htm EX-23.2 5774
8 SECTION 302 CERTIFICATION FOR CEO dex311.htm EX-31.1 7058
9 SECTION 302 CERTIFICATION FOR CFO dex312.htm EX-31.2 7132
10 SECTION 906 CERTIFICATION FOR CEO dex321.htm EX-32.1 3175
11 SECTION 906 CERTIFICATION FOR CFO dex322.htm EX-32.2 3329
  Complete submission text file 0001193125-06-225226.txt   1401819
Mailing Address 2000 POWELL STREET, SUITE 800 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 800 EMERYVILLE CA 94608 510-595-6000
NEUROBIOLOGICAL TECHNOLOGIES INC /CA/ (Filer) CIK: 0000918112 (see all company filings)

EIN.: 943049219 | State of Incorp.: DE | Fiscal Year End: 0630
Type: 10-K | Act: 34 | File No.: 000-23280 | Film No.: 061190929
SIC: 2836 Biological Products, (No Diagnostic Substances)